Cargando…

Mechanisms of Neuronal Death in Synucleinopathy

α-synuclein is a key molecule in the pathogenesis of synucleinopathy including Parkinson's disease and multiple system atrophy. In this mini-review, we mainly focus on recent data obtained from cellular models of synucleinopathy and discuss the possible mechanisms of neurodegeneration. Recent p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takeda, Atsushi, Hasegawa, Takafumi, Matsuzaki-Kobayashi, Michiko, Sugeno, Naoto, Kikuchi, Akio, Itoyama, Yasuto, Furukawa, Katsutoshi
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2006
Materias:	Mini-Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1510951/ https://www.ncbi.nlm.nih.gov/pubmed/17047300 http://dx.doi.org/10.1155/JBB/2006/19365

Ejemplares similares

Suppression of dynamin GTPase decreases α-synuclein uptake by neuronal and oligodendroglial cells: a potent therapeutic target for synucleinopathy
por: Konno, Masatoshi, et al.
Publicado: (2012)

The AAA-ATPase VPS4 Regulates Extracellular Secretion and Lysosomal Targeting of α-Synuclein
por: Hasegawa, Takafumi, et al.
Publicado: (2011)

Hypometabolism in the supplementary and anterior cingulate cortices is related to dysphagia in Parkinson's disease: a cross-sectional and 3-year longitudinal cohort study
por: Kikuchi, Akio, et al.
Publicado: (2013)

Improvement of Freezing of Gait in Patients with Parkinson's Disease by Imagining Bicycling
por: Kikuchi, Akio, et al.
Publicado: (2014)

Unraveling the Complex Interplay between Alpha-Synuclein and Epigenetic Modification
por: Sugeno, Naoto, et al.
Publicado: (2023)

Fatty Acid-Binding Protein 3 Expression in the Brain and Skin in Human Synucleinopathies
por: Oizumi, Hideki, et al.
Publicado: (2021)

ESCRT-0 dysfunction compromises autophagic degradation of protein aggregates and facilitates ER stress-mediated neurodegeneration via apoptotic and necroptotic pathways
por: Oshima, Ryuji, et al.
Publicado: (2016)

Case Report: Guitarist’s cramp as the initial manifestation of dopa-responsive dystonia with a novel heterozygous GCH1 mutation
por: Hasegawa, Takafumi, et al.
Publicado: (2021)

Sudden cardiac death in synucleinopathies
por: Javanshiri, Keivan, et al.
Publicado: (2023)

DnaJ/Hsp40 Family and Parkinson's Disease
por: Hasegawa, Takafumi, et al.
Publicado: (2018)

(18)F-THK5351 Positron Emission Tomography Imaging in Neurodegenerative Tauopathies
por: Ezura, Michinori, et al.
Publicado: (2021)

Neurons and Glia Interplay in α-Synucleinopathies
por: Mavroeidi, Panagiota, et al.
Publicado: (2021)

Retrospective analysis of Guillain–Barré syndrome and Fisher syndrome after the Great East Japan Earthquake
por: Tsuboi, Hirofumi, et al.
Publicado: (2014)

Nicotine-mediated effects in neuronal and mouse models of synucleinopathy
por: Fares, Mohamed Bilal, et al.
Publicado: (2023)

The mechanism of degeneration of striatal neuronal subtypes in Huntington disease
por: Rikani, Azadeh A., et al.
Publicado: (2014)

Targeting Microglial and Neuronal Toll-like Receptor 2 in Synucleinopathies
por: Kwon, Somin, et al.
Publicado: (2019)

Gaucher Disease and the Synucleinopathies
por: Hruska, Kathleen S., et al.
Publicado: (2006)

Anxiety in synucleinopathies: neuronal circuitry, underlying pathomechanisms and current therapeutic strategies
por: Lai, Thuy Thi, et al.
Publicado: (2023)

The Synucleinopathies: Twenty Years On
por: Goedert, Michel, et al.
Publicado: (2017)

Surgical Management of Synucleinopathies
por: Sriram, Sai, et al.
Publicado: (2022)

Histone Deacetylase 6 and the Disease Mechanisms of α-Synucleinopathies
por: Lemos, Miguel, et al.
Publicado: (2020)

Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
por: Brás, Inês C., et al.
Publicado: (2021)

Sustained chemogenetic activation of locus coeruleus norepinephrine neurons promotes dopaminergic neuron survival in synucleinopathy
por: Jovanovic, Predrag, et al.
Publicado: (2022)

The genealogy of genealogy of neurons
por: Moroz, Leonid L
Publicado: (2015)

Disease modifying effect of adiponectin in model of α-synucleinopathies
por: Sekiyama, Kazunari, et al.
Publicado: (2014)

α-Synuclein and Neuronal Cell Death
por: Yasuda, Toru, et al.
Publicado: (2012)

LAG3 is not expressed in human and murine neurons and does not modulate α‐synucleinopathies
por: Emmenegger, Marc, et al.
Publicado: (2021)

Role of α- and β-Synucleins in the Axonal Pathology of Parkinson’s Disease and Related Synucleinopathies
por: Sekigawa, Akio, et al.
Publicado: (2015)

The Role of Glia in Alpha-Synucleinopathies
por: Fellner, Lisa, et al.
Publicado: (2012)

Autonomic Dysfunction in α-Synucleinopathies
por: Mendoza-Velásquez, José Javier, et al.
Publicado: (2019)

Selective vulnerability in α-synucleinopathies
por: Alegre-Abarrategui, Javier, et al.
Publicado: (2019)

The Pharmacology of Visual Hallucinations in Synucleinopathies
por: Russo, Mirella, et al.
Publicado: (2019)

Neuropathology and molecular diagnosis of Synucleinopathies
por: Koga, Shunsuke, et al.
Publicado: (2021)

Inflammation promotes synucleinopathy propagation
por: Kim, Tae-Kyung, et al.
Publicado: (2022)

Diversity of Mitochondrial Pathology in a Mouse Model of Axonal Degeneration in Synucleinopathies
por: Sekigawa, Akio, et al.
Publicado: (2013)

Bcl-2 and the regulation of programmed cell death
Publicado: (1994)

How to make striatal projection neurons
por: Fjodorova, Marija, et al.
Publicado: (2015)

Neuronal regulation of glucagon secretion and gluconeogenesis
por: Thorens, Bernard
Publicado: (2022)

Engineering synucleinopathy‐resistant human dopaminergic neurons by CRISPR‐mediated deletion of the SNCA gene
por: Chen, Yixi, et al.
Publicado: (2018)

Neuroinflammation Upregulated Neuronal Toll-Like Receptors 2 and 4 to Drive Synucleinopathy in Neurodegeneration
por: Chung, Lucia Yi-Ru, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6a0papjlvdc8km2uv72hsjs6kg